Respiratory syncytial virus is the leading cause of hospitalization among U.S. infants. A vaccine, nirsevimab, can reduce the ...
A 6-year-old boy has RSV, strep throat, and pneumonia. His mother never thought a cough could escalate so fast.
The RSVPreF vaccine is safe and demonstrates immunobridging to efficacy among adults aged 18 to 59 who are at high risk for ...
The respiratory syncytial virus (RSV) vaccine may not protect older adults who are immunocompromised as much as their healthier peers, according to new research.
Respiratory viruses including COVID-19, the flu, RSV and pneumonia are on the rise throughout Virginia, according to the ...
RSV is "a common respiratory virus that infects the nose, throat, and lungs. RSV symptoms make it difficult to distinguish it ...
Vaccines to protect against respiratory syncytial virus (RSV) in newborns and older adults are being more widely accepted by ...
Influenza concentrations started to rise in November, and have continued to rise through December. RSV, or respiratory ...
RSV and the flu have taken hold as Chicago residents have partaken in festivities in the last several weeks, and COVID is ...
Taking precautions to protect yourself from the quartet of infectious diseases can lessen your odds of bringing an illness ...